What is the Return on Assets (ROA) of Epigenomics this year?
The Return on Assets (ROA) of Epigenomics is -0.76 undefined this year.
Epigenomics ROA 2024
Epigenomics ROA
-0.76
Ticker
ECX.DE
ISIN
DE000A3H2184
WKN
A3H218
In 2024, Epigenomics's return on assets (ROA) was -0.76, a 670.48% increase from the -0.1 ROA in the previous year.
Epigenomics Aktienanalyse
What does Epigenomics do?
Epigenomics AG is a German biotechnology company specializing in the development of diagnostics for the early detection of cancer. The company is headquartered in Berlin and was founded in 1997. Epigenomics ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Epigenomics's Return on Assets (ROA)
Epigenomics's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Epigenomics's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Epigenomics's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Epigenomics’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Epigenomics stock
What was the ROA of Epigenomics compared to the previous year?
The ROA of Epigenomics has increased by 670.48% compared to the previous year.
What consequences do high ROA have for investors of Epigenomics?
A high ROA is advantageous for investors of Epigenomics, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Epigenomics?
A low ROA can be unfavorable for investors of Epigenomics as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Epigenomics affect the company?
An increase in ROA of Epigenomics can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Epigenomics impact the company?
A reduction in the ROA of Epigenomics can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Epigenomics?
Some factors that can influence the ROA of Epigenomics include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Epigenomics important for investors?
The ROA of Epigenomics is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Epigenomics take to improve ROA?
To improve ROA, Epigenomics can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Epigenomics pay?
Over the past 12 months, Epigenomics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Epigenomics is expected to pay a dividend of 0 EUR.
What is the dividend yield of Epigenomics?
The current dividend yield of Epigenomics is .
When does Epigenomics pay dividends?
Epigenomics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Epigenomics?
Epigenomics paid dividends every year for the past 0 years.
What is the dividend of Epigenomics?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Epigenomics located?
Epigenomics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Epigenomics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Epigenomics from 12/18/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.
When did Epigenomics pay the last dividend?
The last dividend was paid out on 12/18/2024.
What was the dividend of Epigenomics in the year 2023?
In the year 2023, Epigenomics distributed 0 EUR as dividends.
In which currency does Epigenomics pay out the dividend?
The dividends of Epigenomics are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Epigenomics stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Epigenomics
Our stock analysis for Epigenomics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Epigenomics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
